Search

Search Results
Results 821 - 830 of 940 for Chronic fatigue syndrome
  • Opsynvi
    Drug - 6 Feb 2026
    Consumer Medicine Information (CMI) about Opsynvi intended for persons living in Australia.
  • Crestor
    Drug - 21 Jan 2026
    Consumer Medicine Information (CMI) about Crestor intended for persons living in Australia.
  • Columvi
    Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about Columvi intended for persons living in Australia.
  • Tramedo
    Drug - 28 Nov 2025
    Consumer Medicine Information (CMI) about Tramedo intended for persons living in Australia.
  • Low-Protein Diets for Longevity: Benefits, Risks, and Scientific Evidence
    Health - 20 Nov 2025
    Discover how strategic reductions in dietary protein can trigger powerful cellular repair pathways, lower pro-aging signals, and potentially extend healthspan without the demands of chronic calorie...
  • Codalgin Forte
    Drug - 6 Nov 2025
    Consumer Medicine Information (CMI) about Codalgin Forte intended for persons living in Australia.
  • Xolair
    Drug - 29 Oct 2025
    Consumer Medicine Information (CMI) about Xolair intended for persons living in Australia.
  • CoQ10 Benefits: How Coenzyme Q10 Supports Energy, Heart Health, and Anti-Aging
    Health - 20 Oct 2025
    Discover how CoQ10 fuels your body’s energy systems, protects against oxidative damage, and supports heart and metabolic health for optimal vitality.
  • Tramedo SR
    Drug - 13 Oct 2025
    Consumer Medicine Information (CMI) about Tramedo SR intended for persons living in Australia.
  • Prodeine Forte
    Drug - 9 Oct 2025
    Consumer Medicine Information (CMI) about Prodeine Forte intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback